Not recruiting
Type V hyperlipidaemia
Not recruitingInvestigationalNo placebo
Study on Long-Term Safety and Efficacy of ARO-APOC3 for Adults with Mixed Dyslipidemia
InvestigationalNo placebo
- Disease:Type V hyperlipidaemia
- Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues